Welcome to the Inaugural Gene Therapy Potency Assay Summit
Identify, Characterize and Measure Potency to Ensure Safety, Efficacy & Consistency of your Gene Therapy
The Inaugural Gene Therapy Potency Summit (August 29-31) is dedicated to providing you with tools to identify, characterize and measure potency, enabling you to take tactical insights back to your team. The content will focus on the “sweet spot” of drug development where potency is most critical - pre-clinical development through to commercialization.
This is the only industry-led event dedicated to covering all challenges associated with potency for gene therapy drug developers specifically. We will unite with 60+ analytical, bioassay, Quality Control, regulatory and CMC experts to bring together content that gives actionable insights by combining both strategic and technical content.
World-Class Speaker Faculty Includes:
Senior Director - Pharmaceutical Development
Ultragenyx Pharmaceutical Inc
Vice President - Analytical Development & Product Lead
Director - Analytical Development
Vice President - Analytical Development & Quality Control
Senior Director - Analytical Development
Previously Attending Companies Include:
"Very informative and intellectually stimulating with engaged participants and high-quality speakers."
Senior Scientist - Analytical Development, Novartis Gene Therapies